Herkes Claire

Gartner, INc · EVP

Herkes Claire is listed in public filings as officer: EVP, Conferences. This Herkes Claire insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Gartner, INc (IT). Investors use Herkes Claire's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Gartner, INcIT--976 sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable976 shares----
Gartner, INcIT--892 sharesGrant / ExerciseFeb 9, 2026Disclosure amount unavailable892 shares----
Gartner, INcIT$907k5.7k sharesGrant / ExerciseFeb 9, 2026$48.9K306 shares$159.75--
Gartner, INcIT$1.0M6.3k sharesGrant / ExerciseFeb 9, 2026$44.7K280 shares$159.75--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Gartner, INcIT--1.7k sharesGrant / ExerciseFeb 8, 2026Disclosure amount unavailable850 shares----
Gartner, INcIT$783k5k sharesGrant / ExerciseFeb 8, 2026$43.3K277 shares$156.33--
Gartner, INcIT--1.7k sharesGrant / ExerciseFeb 6, 2026Disclosure amount unavailable576 shares----
Gartner, INcIT$693k4.4k sharesGrant / ExerciseFeb 6, 2026$33.5K214 shares$156.33--
Gartner, INcIT$2.1M14k sharesGrant / ExerciseFeb 5, 2026$2.1M14k shares$152.03--
Gartner, INcIT--2.3k sharesGrant / ExerciseFeb 5, 2026Disclosure amount unavailable2.3k shares----
Gartner, INcIT$943k4.1k sharesSellDec 3, 2025$85.0K367 shares$231.56--
Gartner, INcIT$1.1M4.8k sharesOtherNov 28, 2025$551.4K2.4k shares$232.74--
Gartner, INcIT$03.1k sharesGrant / ExerciseNov 28, 2025$551.3K3.1k shares$180.64--
Gartner, INcIT$1.0M4.4k sharesGrant / ExerciseNov 28, 2025$73.5K316 shares$232.74--